RxSight Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Raised Its FY24 Revenue Guidance Above Estimates. Also, Multiple Firms Raised Their Respective Price Targets on the Stock
RxSight公佈的第一季度財務業績好於預期,並將24財年收入指引提高至預期以上,此後,該公司股價走高。此外,多家公司提高了各自的股票目標股價